Monday 28th March 2022, 6.00pm – 9.30pm
Programme
6.00 pm Mello Welcome
6.05 pm Company presentation by Fintel
6.35 pm Company presentation by Poolbeg Pharma
7.05 pm Behind the Balance Sheet with Steve Clapham
7.20 pm Company presentation by Music Magpie
8.00 pm Mello BASH panel with Mark Simpson and Kevin Taylor
Company Presentation – Poolbeg Pharma plc (LON:POLB)
Poolbeg Pharma is a clinical stage infectious disease pharmaceutical company, with a capital light clinical model which aims to develop multiple products faster and more cost effectively than the conventional biotech model. The Company, headquartered in London, is led by a team with a track record of creation and delivery of shareholder value and aspires to become a “one-stop shop” for Big Pharma seeking mid-stage products to licence or acquire.
The Company is targeting the growing infectious disease market. In the wake of the COVID-19 pandemic, infectious disease has become one of the fastest growing pharma markets and is expected to exceed $250bn by 2025.
With its initial assets from Open Orphan plc, an industry leading infectious disease and human challenge trials business, Poolbeg has access to knowledge, experience, and clinical data from over 20 years of human challenge trials. The Company is using these insights to acquire new assets as well as reposition clinical stage products, reducing spend and risk. It already has a Phase II ready repositioned small molecule immunomodulator for severe influenza and a portfolio of other exciting assets. The Company plans to broaden this portfolio further going forward and is in active discussions with AI data analysis platforms to help accelerate the power of its human challenge model data and biobank.
For more information, please go to www.poolbegpharma.com or follow us @PoolbegPharma.
Jeremy Skillington, CEO
Jeremy began his biotechnology career in the Business Development group of Genentech, Inc in California in 2002. At Genentech he was responsible for executing over 40 licensing, investment and collaboration transactions. Returning to Ireland in 2009, he then led Business Development and was a member of the Senior Management team at Opsona Therapeutics Ltd before becoming a founder and CEO of immuno-oncology company TriMod Therapeutics Ltd.
He joined German investment fund HS Lifesciences GmbH in 2014 to provide start-up and business development support to portfolio companies ImmunoQure AG and Ethris GmbH.
He joined Inflazome on its founding in 2016 and was instrumental in their acquisition by Roche in September, 2020 for €380M (£325M) upfront and significant downstream milestone payments.
Jeremy studied Biochemistry at the National University of Ireland, Galway where he was awarded his Ph.D. He performed his post-doctoral research at the University of California, San Francisco in the lab of Prof Rik Derynck.
Cathal is 56 years-old, and is an entrepreneur, starting work at 16 years due to his father’s untimely illness he went on to complete his education at night classes and got an MBA from the University of Ulster in 1990. He spent the following five years lecturing part time in International Marketing and Business Planning at the University of Ulster, while running his own new technology services business.
In 2001 he was part of the team who successfully established Merrion Stockbrokers in Dublin and in 2007 he founded Raglan Capital. Cathal is the Executive Chairman and Co-Founder of Open Orphan plc which IPO’d on the London and Dublin stock exchanges in June 2019. He also co-founded Amryt Pharma plc in 2015 along with Joe Wiley, which is listed on the London stock exchange since 2016 and which listed on Nasdaq in July 2020.
Prior to Amryt, Cathal founded Fastnet Oil & Gas plc in 2011 which he IPO’d on the London stock exchange. Cathal is a finalist in the International category as part of the EY Entrepreneur of the Year 2020.
Cathal Friel, Chairman
Company Presentation – musicMagpie
musicMagpie is a leader in the re-commerce of consumer technology (including smartphones, tablets, consoles and wearables), disc media (including CDs, DVDs and games) and books, with sustainability running to the very heart of its operations. The business has a clear strategic growth plan to buy more, sell more and rent more.
Founded in 2007, the Group has an established presence in the UK, with operations in Stockport, Greater Manchester, and in the US in Atlanta, Georgia. Operating through its two trusted brands – musicMagpie in the UK and decluttr in the US – the Group’s core business model is simple: to provide consumers with a smart, sustainable and trusted way to buy, rent and sell refurbished consumer technology and physical media products.
The Group has the highest number of seller reviews on both Amazon and eBay and has consistently achieved extremely positive feedback scores. The Group also has a 4.6* rating on UK Trustpilot with over 215,000 reviews.
Steve Oliver, CEO & Co-founder
Steve Oliver was appointed to the Board on 7 December 2020. He graduated from The University of Sheffield in 1992 with a degree in Psychology. He joined Hawsons Chartered Accountants in 1992, where he passed the ACA Foundation Stages before moving to Downham Morris Mayer Accountants in Stockport in 1994. He moved into industry at Eurokit UK Limited as their Financial Controller in 1995. He then became Finance Director of Fibreply Limited in 1998. In September 2000, Mr. Oliver joined Music Zone Services Limited (“Music Zone”), firstly as Finance Director, but shortly after becoming Managing Director, a role he held until 2007. He then briefly held the role of Interim Managing Director at Famous Retail Limited, a sports memorabilia retailer, before founding musicMagpie later that year. In March 2008, he was appointed Managing Director of TFS Buying Limited (trading as The Fragrance Shop), which he left in late 2009 to focus on the Group full time.
Ian Storey, Group Chief Operating Officer
Ian Storey graduated from the University of Leicester in 1998 with a degree in Law (2:1). He joined Deloitte LLP in September 1998 and trained in the audit department, becoming ACA qualified in May 2001. He joined iSoft plc in September 2002 as an internal reporting accountant, and subsequently held a number of financial roles within iSoft plc, including that of Financial Controller, until his departure in December 2006. Mr. Storey joined Ultimate Products Limited in December 2006 and was promoted to Finance Director in March 2007 before moving to the role of Executive Buying Director in 2010. Mr. Storey left Ultimate Products in March 2012 and worked as a consultant until he joined musicMagpie as Commercial Finance Manager in January 2013. He was subsequently appointed to the EMGL board as Chief Financial Officer of the EMGL Group in March 2015 and will become Group Chief Operating Officer on or around the date of Admission.
Company Presentation – Fintel plc (LON)
Fintel is the UK’s leading fintech and support services business, combining the largest provider of intermediary business support, SimplyBiz, and the leading research, ratings, and Fintech business, Defaqto. Fintel provides technology, compliance and regulatory support to thousands of intermediary businesses, data and targeted distribution services to hundreds of product providers and empowers millions of consumers to make better informed financial decisions. We serve our customers through three core divisions:
The Intermediary Services division provides technology, compliance, and regulatory support to thousands of intermediary businesses through a comprehensive membership model. Members include directly authorised IFAs, Wealth Managers and Mortgage Brokers.
The Distribution Channels division delivers market Insight & analysis and targeted distribution strategies to financial institutions and product providers. Clients include major Life & Pension companies, Investment Houses, Banks and Building Societies
The Fintech and Research division (Defaqto) provides market leading software, financial information and product research to product providers and intermediaries. Defaqto also provides product ratings (Star Ratings) on thousands of financial products. Financial products are expertly reviewed by the Defaqto research team and are compared and rated based on their underlying features & benefits. Defaqto ratings help consumers compare and buy financial products with confidence.
For more information about Fintel, please visit the website: www.wearefintel.com
Neil has executive responsibility for the operations and governance of Fintel, with a strong background in business delivery and creating innovative propositions. Neil works closely with the UK life, pensions and investment industries to deliver solutions for advisers and has been active in many industry forums.
Neil joined SimplyBiz in 2003 as a consultant before being appointed to the Board in 2004. He was appointed Joint CEO of Fintel (formerly The SimplyBiz Group) in 2010 and is the Executive Chairman of Defaqto.
He has worked as a management consultant in the UK and Europe and has an engineering degree from UCE and an MBA from Manchester Metropolitan University.
Matt has executive responsibility for the sales and marketing activities, as well as key strategic relationships with both insurance and investment companies. Alongside Neil Stevens, he is leading the Vision and Strategy for Fintel.
Matt joined SimplyBiz at its inception in 2002 as Marketing Director and was appointed Joint CEO of Fintel (formerly The SimplyBiz Group) in 2010.
Matt runs several of the key subsidiaries within the business including SimplyBiz Services, SimplyBiz Mortgages, Gateway Surveyors and SimplyBiz Support. Previous employment includes GE Capital, Misys and DBS Financial Management.
David is responsible for financial strategy of Fintel, overseeing all aspects of financial planning and reporting and management of financial risks.
David joined Fintel in April 2021 as CFO, bringing with him a broad range of commercial and management experience. David is a qualified chartered accountant and has held senior public practice and industry roles, gaining exposure to a variety of commercial and technical issues.
Most recently, he has been the CFO at AIM-listed Smart Metering Systems (SMS), after being promoted from group and divisional finance director in 2017. He has also held a number of senior finance positions at Energetics Utility Group, Johnston Carmichael and PwC.
The Mello BASH (Buy, Avoid, Sell & Hold)
Kevin Taylor Professional Private Investor
Mark Simpson Private Investor
MelloMonday Sponsors
Hardman & Co is a multi-disciplinary financial consultancy and investment research firm, employing highly experienced analysts and professionals with a broad range of capital markets expertise.
Click here for Hardman & Co research.
Progressive introduces you to new investment ideas. FCA authorised and regulated, we provide freely available equity research and connect investors with companies across every sector of the market.
Click here to receive our research and be invited to our regular investor events.